Trust Homepage > Pathology Homepage

Test and Tubes Database
ID:918 Danaparoid (Orgaran) Assay
Search Links: General Info : Protocols : Patient Info

DescriptionDanaparoid is a heparinoid substitute that is used in patients that have Heparin Induced Thrombocytopaenia.
IndicationPatients on Danaparoid therapy.
Additional InfoDanaparoid active components consist of heparin sulphate, dermatan sulphate, and chondroitin sulphate. Danaparoid differs from other low molecular weight heparins is that Danaparoid is devoid of heparin or heparin fragments. Similarly to LMWH's, it exerts its antithrombotic effect principally through anti-thrombin mediated inhibition of factor Xa, and to a much lesser extent, thrombin.
Concurrent TestsNone
Dietary RequirementsNone

InterpretationInterpreted against a therapeutic range dependant on clinical details.

Ref. Range (Male)
Ref. Range (Female)
Ref. Range (Paed)
Ref. Range NotesCritical telephone values: Danaparoid levels greater than 1.5IU/mL Interpreted against a therapeutic range dependant on clinical details
Unitsug/mL

Other Help:National Laboratory Medicine Handbook

IP Acute TAT- Contact Laboratory
IP Routine TAT24 hours
GP Acute TAT- Contact Laboratory
GP Routine TAT24 hours
Turnround CommentSpecialist test only to be requested by a medical haematologist
Originally edited by : RJAR. Last edited on 18/06/2019 10:31:47. Published By RJAR on 18/06/2018 10:31:47.